IT’S no secret companies and bankers trying to get public floats away are having nervous nights. But executives at GI Dynamics, which could become the second-biggest initial public offering of the year with a market value of more than $300 million, are optimistic. “We continue to be excited by the response that we have seen and heard and we’re pushing forward,” said chief executive Stuart Randle from the biotech’s US base in Massachusetts. Investment bankers are suffering through one of the driest spells for IPOs in about a decade, with Collins Foods the largest deal at $200m.
